- Study: NPs strengthening focus on promoting patient adherence
- Study from NCPA sheds new light on med synchronization programs
- CDC publishes guidelines for collaborative practice agreements
- Vitals predicts consumer healthcare trends for 2014
- EMD Serono releases redesigned injector pen for infertility
CHARLOTTESVILLE, Va. — A new at-home test that analyzes a male's sperm count has entered the market.
SpermCheck Fertility is an at-home, noninvasive screening test for men that's designed to determine "normal" to "low" sperm count with 98% accuracy, according to the manufacturer. The 10-minute test indicates if sperm count is within “normal” range (at or above 20 million sperm per mL, which is the accepted standard for normal sperm count) or "low," which would indicate that a visit to the physician for further analysis of the man is in order. Currently available online at CVS.com and Walgreens.com, the product is rolling out to stores nationwide in April and carries a suggested retail price of $39.99.
“Men have historically avoided this type of semen analysis because it can be embarrassing and inconvenient for them to go to a physician or lab for this type of test, yet approximately 50% of all infertility problems are directly attributed to the male, and most of them are mainly due to low sperm count,” SpermCheck CEO Ray Lopez said. “With such high incidence of fertility issues, coupled with low incidence of male testing, we saw a great opportunity to provide couples with an at-home test that can provide information that is crucial for conception preparation, yet takes the stigma out of the test, since it is done in the privacy of their own home.”